Amedisys Stock (NASDAQ:AMED)


ForecastRevenueOwnershipFinancialsChart

Previous Close

$83.78

52W Range

$82.17 - $98.95

50D Avg

$91.85

200D Avg

$94.20

Market Cap

$2.77B

Avg Vol (3M)

$517.13K

Beta

0.78

Div Yield

-

AMED Company Profile


Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, Personal Care, and High Acuity Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including cancer, heart disease, pulmonary disease, or Alzheimer's. The Personal Care segment provides assistance for patients with the activities of daily living. The High Acuity Care offers essential elements of inpatient hospital, skilled nursing facility care and palliative care to patients in their homes. As of December 31, 2021, the company owned and operated 331 home health care centers, 175 hospice care centers, and 14 personal-care, and 8 high acuity care centers in 38 states within the United States and the District of Columbia. Amedisys, Inc. was incorporated in 1982 and is headquartered in Baton Rouge, Louisiana.

Show More

Industry

Medical - Care Facilities

Sector

Healthcare

Exchange

NASDAQ

ADR

-

Country

US

Employees

19,000

IPO Date

Aug 17, 1994

Website

AMED Performance


Revenue Breakdown


Revenue Breakdown by Product/Service

Product/ServiceDec 23Dec 22Dec 21
Hospice$798.80M$787.80M$791.80M
Personal Care$15.00M$61.40M$65.00M
High Acuity Care$19.00M$18.50M$3.50M
Home Health$1.40B$1.36B$1.35B

Fiscal year ends in Dec 23 | Currency in USD

AMED Financial Summary


Dec 23Dec 22Dec 21
Revenue$2.24B$2.22B$2.21B
Operating Income$156.39M$180.77M$251.91M
Net Income$90.18M$118.61M$209.07M
EBITDA$26.10M$256.44M$329.92M
Basic EPS$2.77$3.65$6.41
Diluted EPS$2.77$3.63$6.34

Fiscal year ends in Dec 23 | Currency in USD

Latest Earnings Call Transcripts


Q4 22Feb 16, 23 | 4:28 PM
Q3 22Oct 27, 22 | 5:42 PM
Q2 22Jul 28, 22 | 5:10 PM

Peer Comparison


TickerCompany
SGRYSurgery Partners, Inc.
EHABEnhabit, Inc.
EHCEncompass Health Corporation
HCSGHealthcare Services Group, Inc.
OPCHOption Care Health, Inc.
ENSGThe Ensign Group, Inc.
INNVInnovAge Holding Corp.
PNTGThe Pennant Group, Inc.
UHSUniversal Health Services, Inc.
ACHCAcadia Healthcare Company, Inc.
ADUSAddus HomeCare Corporation